Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

July 01, 1998; Volume 26,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ackland, Mark J.

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
  2. Allard, Stéphane

    1. You have access
      Minimal Interaction Between Fluoxetine and Multiple-Dose Zolpidem in Healthy Women
      Stéphane Allard, Stephen Sainati, Barbara Roth-Schechter and John MacIntyre
      Drug Metabolism and Disposition July 1998, 26 (7) 617-622;
  3. Anders, M. W.

    1. You have access
      Metabolism of 1,1-Dichloro-1-fluoroethane (HCFC-141b) in Human Volunteers
      Zeen Tong, Mark J. Utell, Paul E. Morrow, George M. Rusch and M. W. Anders
      Drug Metabolism and Disposition July 1998, 26 (7) 711-713;
  4. Angerbauer, Rolf

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;

B

  1. Bazin-Redureau, M.

    1. You have access
      Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver
      G. Hong, M. Bazin-Redureau, P. Gires and J. M. Scherrmann
      Drug Metabolism and Disposition July 1998, 26 (7) 661-669;
  2. Bend, John R.

    1. You have access
      Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 byN-(α-Methylbenzyl)-1-Aminobenzotriazole
      Christopher J. Sinal, Maurice Hirst, Christopher D. Webb and John R. Bend
      Drug Metabolism and Disposition July 1998, 26 (7) 681-688;
  3. Birnbaum, Linda S.

    1. You have access
      Effects of Age, Sex, and Pharmacologic Agents on the Biliary Elimination of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in F344 Rats
      Joseph A. Jackson, Linda S. Birnbaum and Janet J. Diliberto
      Drug Metabolism and Disposition July 1998, 26 (7) 714-719;
  4. Bistner, Steve

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
  5. Boberg, Michael

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  6. Brattsand, R.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;

C

  1. Claffey, David J.

    1. You have access
      Fentanyl in Hair
      Peter R. Stout, David J. Claffey and James A. Ruth
      Drug Metabolism and Disposition July 1998, 26 (7) 689-700;

D

  1. Dahlbäck, M.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;
  2. Diliberto, Janet J.

    1. You have access
      Effects of Age, Sex, and Pharmacologic Agents on the Biliary Elimination of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in F344 Rats
      Joseph A. Jackson, Linda S. Birnbaum and Janet J. Diliberto
      Drug Metabolism and Disposition July 1998, 26 (7) 714-719;
  3. Du, Bert N. La

    1. You have access
      Calcium Binding by Human and Rabbit Serum Paraoxonases
      Chung-Liang Kuo and Bert N. La Du
      Drug Metabolism and Disposition July 1998, 26 (7) 653-660;

G

  1. Gires, P.

    1. You have access
      Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver
      G. Hong, M. Bazin-Redureau, P. Gires and J. M. Scherrmann
      Drug Metabolism and Disposition July 1998, 26 (7) 661-669;

H

  1. Hauer, Michael J.

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
  2. Henry, Scott P.

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
  3. Hirst, Maurice

    1. You have access
      Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 byN-(α-Methylbenzyl)-1-Aminobenzotriazole
      Christopher J. Sinal, Maurice Hirst, Christopher D. Webb and John R. Bend
      Drug Metabolism and Disposition July 1998, 26 (7) 681-688;
  4. Hjertberg, E.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;
  5. Hong, G.

    1. You have access
      Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver
      G. Hong, M. Bazin-Redureau, P. Gires and J. M. Scherrmann
      Drug Metabolism and Disposition July 1998, 26 (7) 661-669;
  6. Horwatt, Peter M.

    1. You have access
      Isolation and Identification of Bromfenac Glucoside From Rat Bile
      Sandra K. Kirkman, Mei-Yi Zhang, Peter M. Horwatt and JoAnn Scatina
      Drug Metabolism and Disposition July 1998, 26 (7) 720-723;

J

  1. Jackson, Joseph A.

    1. You have access
      Effects of Age, Sex, and Pharmacologic Agents on the Biliary Elimination of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in F344 Rats
      Joseph A. Jackson, Linda S. Birnbaum and Janet J. Diliberto
      Drug Metabolism and Disposition July 1998, 26 (7) 714-719;
  2. Ju, C.

    1. You have access
      Oxidation of a Metabolite of Indomethacin (Desmethyldeschlorobenzoylindomethacin) to Reactive Intermediates by Activated Neutrophils, Hypochlorous Acid, and the Myeloperoxidase System
      C. Ju and J. P. Uetrecht
      Drug Metabolism and Disposition July 1998, 26 (7) 676-680;

K

  1. Kanhai, Wolfgang K.

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  2. Karl, Wolfgang

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  3. Kern, Armin

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  4. Kerr, Bradley M.

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
  5. Khojasteh-Bakht, Siamak C.

    1. You have access
      (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
      Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson
      Drug Metabolism and Disposition July 1998, 26 (7) 701-704;
  6. Kirkman, Sandra K.

    1. You have access
      Isolation and Identification of Bromfenac Glucoside From Rat Bile
      Sandra K. Kirkman, Mei-Yi Zhang, Peter M. Horwatt and JoAnn Scatina
      Drug Metabolism and Disposition July 1998, 26 (7) 720-723;
  7. Koenigs, Luke L.

    1. You have access
      (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
      Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson
      Drug Metabolism and Disposition July 1998, 26 (7) 701-704;
  8. Kuo, Chung-Liang

    1. You have access
      Calcium Binding by Human and Rabbit Serum Paraoxonases
      Chung-Liang Kuo and Bert N. La Du
      Drug Metabolism and Disposition July 1998, 26 (7) 653-660;

L

  1. Lee, Caroline A.

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
  2. Leeds, Janet M.

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
  3. Levin, Arthur A.

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
  4. Liang, Bai Hong

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
  5. Lillibridge, James H.

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;

M

  1. MacIntyre, John

    1. You have access
      Minimal Interaction Between Fluoxetine and Multiple-Dose Zolpidem in Healthy Women
      Stéphane Allard, Stephen Sainati, Barbara Roth-Schechter and John MacIntyre
      Drug Metabolism and Disposition July 1998, 26 (7) 617-622;
  2. Maio, Stephen M.

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
  3. Mattsson, H.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;
  4. Miller-Larsson, A.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;
  5. Morrow, Paul E.

    1. You have access
      Metabolism of 1,1-Dichloro-1-fluoroethane (HCFC-141b) in Human Volunteers
      Zeen Tong, Mark J. Utell, Paul E. Morrow, George M. Rusch and M. W. Anders
      Drug Metabolism and Disposition July 1998, 26 (7) 711-713;

N

  1. Nelson, Sidney D.

    1. You have access
      (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
      Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson
      Drug Metabolism and Disposition July 1998, 26 (7) 701-704;

P

  1. Payne, N. Ann

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
  2. Peter, Raimund M.

    1. You have access
      (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
      Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson
      Drug Metabolism and Disposition July 1998, 26 (7) 701-704;

Q

  1. Quart, Barry

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;

R

  1. Radtke, Martin

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  2. Roth-Schechter, Barbara

    1. You have access
      Minimal Interaction Between Fluoxetine and Multiple-Dose Zolpidem in Healthy Women
      Stéphane Allard, Stephen Sainati, Barbara Roth-Schechter and John MacIntyre
      Drug Metabolism and Disposition July 1998, 26 (7) 617-622;
  3. Rusch, George M.

    1. You have access
      Metabolism of 1,1-Dichloro-1-fluoroethane (HCFC-141b) in Human Volunteers
      Zeen Tong, Mark J. Utell, Paul E. Morrow, George M. Rusch and M. W. Anders
      Drug Metabolism and Disposition July 1998, 26 (7) 711-713;
  4. Ruth, James A.

    1. You have access
      Fentanyl in Hair
      Peter R. Stout, David J. Claffey and James A. Ruth
      Drug Metabolism and Disposition July 1998, 26 (7) 689-700;

S

  1. Sainati, Stephen

    1. You have access
      Minimal Interaction Between Fluoxetine and Multiple-Dose Zolpidem in Healthy Women
      Stéphane Allard, Stephen Sainati, Barbara Roth-Schechter and John MacIntyre
      Drug Metabolism and Disposition July 1998, 26 (7) 617-622;
  2. Sanders, Philip E.

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;
  3. Scatina, JoAnn

    1. You have access
      Isolation and Identification of Bromfenac Glucoside From Rat Bile
      Sandra K. Kirkman, Mei-Yi Zhang, Peter M. Horwatt and JoAnn Scatina
      Drug Metabolism and Disposition July 1998, 26 (7) 720-723;
  4. Scherrill, Scott

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;
  5. Scherrmann, J. M.

    1. You have access
      Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver
      G. Hong, M. Bazin-Redureau, P. Gires and J. M. Scherrmann
      Drug Metabolism and Disposition July 1998, 26 (7) 661-669;
  6. Shetty, Bhasker V.

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
  7. Sinal, Christopher J.

    1. You have access
      Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 byN-(α-Methylbenzyl)-1-Aminobenzotriazole
      Christopher J. Sinal, Maurice Hirst, Christopher D. Webb and John R. Bend
      Drug Metabolism and Disposition July 1998, 26 (7) 681-688;
  8. Steinke, Wolfram

    1. You have access
      Biotransformation of Cerivastatin in Mice, Rats, and Dogsin vivo
      Michael Boberg, Rolf Angerbauer, Wolfgang K. Kanhai, Wolfgang Karl, Armin Kern, Martin Radtke and Wolfram Steinke
      Drug Metabolism and Disposition July 1998, 26 (7) 640-652;
  9. Stout, Peter R.

    1. You have access
      Fentanyl in Hair
      Peter R. Stout, David J. Claffey and James A. Ruth
      Drug Metabolism and Disposition July 1998, 26 (7) 689-700;

T

  1. Tong, Zeen

    1. You have access
      Metabolism of 1,1-Dichloro-1-fluoroethane (HCFC-141b) in Human Volunteers
      Zeen Tong, Mark J. Utell, Paul E. Morrow, George M. Rusch and M. W. Anders
      Drug Metabolism and Disposition July 1998, 26 (7) 711-713;
  2. Trager, William F.

    1. You have access
      (R)-(+)-Menthofuran Is a Potent, Mechanism-Based Inactivator of Human Liver Cytochrome P450 2A6
      Siamak C. Khojasteh-Bakht, Luke L. Koenigs, Raimund M. Peter, William F. Trager and Sidney D. Nelson
      Drug Metabolism and Disposition July 1998, 26 (7) 701-704;
  3. Tunek, A.

    1. You have access
      Reversible Fatty Acid Conjugation of Budesonide
      A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlbäck, A. Tunek and R. Brattsand
      Drug Metabolism and Disposition July 1998, 26 (7) 623-630;

U

  1. Uematsu, Takayoshi

    1. You have access
      Biotransformation of Nitroso Aromatic Compounds and 2-Oxo Acids to N-Hydroxy-N-arylacylamides by Thiamine-Dependent Enzymes in Rat Liver
      Tadao Yoshioka and Takayoshi Uematsu
      Drug Metabolism and Disposition July 1998, 26 (7) 705-710;
  2. Uetrecht, J. P.

    1. You have access
      Oxidation of a Metabolite of Indomethacin (Desmethyldeschlorobenzoylindomethacin) to Reactive Intermediates by Activated Neutrophils, Hypochlorous Acid, and the Myeloperoxidase System
      C. Ju and J. P. Uetrecht
      Drug Metabolism and Disposition July 1998, 26 (7) 676-680;
  3. Utell, Mark J.

    1. You have access
      Metabolism of 1,1-Dichloro-1-fluoroethane (HCFC-141b) in Human Volunteers
      Zeen Tong, Mark J. Utell, Paul E. Morrow, George M. Rusch and M. W. Anders
      Drug Metabolism and Disposition July 1998, 26 (7) 711-713;

V

  1. Voorman, Richard L.

    1. You have access
      Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A
      Richard L. Voorman, Stephen M. Maio, Michael J. Hauer, Philip E. Sanders, N. Ann Payne and Mark J. Ackland
      Drug Metabolism and Disposition July 1998, 26 (7) 631-639;

W

  1. Webb, Christopher D.

    1. You have access
      Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 byN-(α-Methylbenzyl)-1-Aminobenzotriazole
      Christopher J. Sinal, Maurice Hirst, Christopher D. Webb and John R. Bend
      Drug Metabolism and Disposition July 1998, 26 (7) 681-688;
  2. Webber, Stephanie

    1. You have access
      Characterization of the Selectivity and Mechanism of Human Cytochrome P450 Inhibition by the Human Immunodeficiency Virus-Protease Inhibitor Nelfinavir Mesylate
      James H. Lillibridge, Bai Hong Liang, Bradley M. Kerr, Stephanie Webber, Barry Quart, Bhasker V. Shetty and Caroline A. Lee
      Drug Metabolism and Disposition July 1998, 26 (7) 609-616;
  3. Williams, Kevin

    1. You have access
      Pharmacokinetics of an Antisense Oligonucleotide Injected Intravitreally in Monkeys
      Janet M. Leeds, Scott P. Henry, Steve Bistner, Scott Scherrill, Kevin Williams and Arthur A. Levin
      Drug Metabolism and Disposition July 1998, 26 (7) 670-675;

Y

  1. Yoshioka, Tadao

    1. You have access
      Biotransformation of Nitroso Aromatic Compounds and 2-Oxo Acids to N-Hydroxy-N-arylacylamides by Thiamine-Dependent Enzymes in Rat Liver
      Tadao Yoshioka and Takayoshi Uematsu
      Drug Metabolism and Disposition July 1998, 26 (7) 705-710;

Z

  1. Zhang, Mei-Yi

    1. You have access
      Isolation and Identification of Bromfenac Glucoside From Rat Bile
      Sandra K. Kirkman, Mei-Yi Zhang, Peter M. Horwatt and JoAnn Scatina
      Drug Metabolism and Disposition July 1998, 26 (7) 720-723;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 26, Issue 7
1 Jul 1998
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Read
Loading
  • Predictable Cross-Species Translation of GalNAc-Conjugated siRNA
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • ADME of Therapeutic Proteins
  • PK and Biodistribution of Therapeutic Proteins
  • An IQ Perspective of Therapeutic Protein Biotransformation
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics